Search

everythinglearnresearchcommunity

for

Search:↓

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Monitor methotrexate side effects, research cannabis treatments, and use mycophenolate mofetil for lupus nephritis.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Methylprednisolone treatment helps most alopecia areata patients, but young age, extensive hair loss, and low vitamin D can affect results.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Brodalumab is more effective than ustekinumab in treating psoriasis.